SCHEMBL5457909

SCHEMBL5457909

CCOc1cccc(NC(=O)Nc2ccc(C3=CCN(C(=O)Nc4ncc(F)cc4F)CC3)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
ALDH1A1 P00352 4/20 0.52
NPC1 O15118 2/20 0.52
ALOX15 P16050 2/20 0.52
RAB9A P51151 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
HPGD P15428 1/20 0.52
CASP3 P42574 1/20 0.52
SENP8 Q96LD8 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
LMNA P02545 2/20 0.49
HTT P42858 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
NAMPT P43490 6/20 0.46
TSHR P16473 1/20 0.44
LIMK1 P53667 4/20 0.42
LIMK2 P53671 4/20 0.42
TRPV1 Q8NER1 3/20 0.42
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456882 0.83 MAPT (0.49) MAPTALDH1A1NPC1ALOX15RAB9A
SCHEMBL5460590 0.83 MAPT (0.52) MAPTALDH1A1NPC1ALOX15RAB9A
SCHEMBL5549910 0.83 NPC1 (0.50) MAPTALDH1A1NPC1ALOX15RAB9A
SCHEMBL5465544 0.82 NPC1 (0.55) MAPTALDH1A1NPC1ALOX15RAB9A
SCHEMBL5467429 0.82 MAPT (0.48) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL5465574 0.79 CASP3 (0.47) MAPTALDH1A1NPC1ALOX15RAB9A
SCHEMBL5458375 0.79 NAMPT (0.58) MAPTALDH1A1NPC1ALOX15RAB9A
SCHEMBL4107028 0.73 SMN1; SMN2 (0.64) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL5460880 0.71 MAPT (0.49) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL5452210 0.71 RAB9A (0.55) MAPTALDH1A1NPC1ALOX15RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 MAPT 758/4885ALDH1A1 731/4885NPC1 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.